Delhi High Court Gives Nod to Biocon, Mylan to Sell Biosimilar Cancer Drug - 06.03.2017

Delhi High Court gave a green signal to pharmaceutical companies Biocon and Mylan to manufacture and sell its biosimilar drug Trastuzumab for early breast cancer and metastatic gastric cancer.

Tags : Delhi High Court Biosimilar Cancer Drug

Share :